Immutep Ltd Files Routine 6-K Disclosure
Ticker: PRRUF · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, routine-filing
TL;DR
IMMUTEP filed a 6-K, just a routine update, no major news.
AI Summary
Immutep Limited filed a Form 6-K on July 30, 2025, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the pharmaceutical preparations sector. This filing does not contain specific financial updates or material events but serves as a routine disclosure.
Why It Matters
This filing indicates Immutep is meeting its ongoing disclosure obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine filing and does not contain new material information that would typically impact risk.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- July 30, 2025 (date) — Filing date
- 001-35428 (other) — Commission file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or that it has filed or will file with a stock exchange.
What is Immutep Limited's former company name?
Immutep Limited's former company name was Prima BioMed Ltd.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is July 30, 2025.
Does Immutep Limited file annual reports under Form 20-F or 40-F?
Immutep Limited indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding IMMUTEP Ltd (PRRUF).